Clinical Trial Update: Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of Ziltivekimab on coronary atherosclerotic burden in patients after acute myocardial infarction. The study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Atherosclerosis
• Myocardial Infarction

Drugs mentioned

• Ziltivekimab

Snippet

Sponsor: ECRI bv | Conditions: Coronary Artery Disease, Acute Myocardial Infarction (AMI) | Phase 3 | Status: RECRUITING